Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

Condition:   Metastatic Thyroid Cancer
Interventions:   Drug: Cyclophosphamide;   Drug: Sirolimus
Sponsor:   University of Michigan Cancer Center
Not yet recruiting - verified March 2017

http://ift.tt/2nGRgQ0